U-PGx – Ubiquitous Pharmacogenomics. Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen
Pharmacogenomics (PGx) is the study of genetic variability affecting an individual’s response to a drug. Clinical application of pharmacogenomics knowledge will result in less ‘trial and error’ prescribing and more efficacious, safer and cost-effective drug therapy. However, despite the major advances in PGx and several commercially available PGx tests, its application in routine patient care remains very limited.
The U-PGx consortium will address major challenges and obstacles for implementation of PGx testing in patient care, taking into account the diversity of healthcare systems and citizens across Europe.
- Researcher: Cristina Lucía Dávila Fajardo
- Group: TEC01-PRÁCTICA SEGURA EN EL USO DE MEDICAMENTOS
- Center: San Cecilio University Hospital
- Rol in the project: Work Package Leader
- Duration: 2016 – 2020
Página web del proyecto: https://upgx.eu/